FRIEDMAN PAUL A sold MDGL
August 12, 2025 · Form 4 insider transaction
FRIEDMAN PAUL A sold 8,434 shares of Madrigal Pharmaceuticals, Inc. at $357.93 per share, a transaction worth $3.02M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
8,434
Price
$357.93
Total value
$3.02M
InsiderFRIEDMAN PAUL A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 12, 2025
Filing dateAugust 13, 2025
Shares owned after192,796
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.48 to $358.47, inclusive.